Skip to main content
. 2011 Jul 11;6:1487–1496. doi: 10.2147/IJN.S18535

Figure 2.

Figure 2

A) Scanning electron micrographs of doxorubicin–dextran sulfate (DOX-DS) nanocomplexes (DOX: 60 μg/mL, DS/DOX [w/w]: 0.6), B) UV-visible spectrum of DOX-DS complex and free DOX, and C) fluorescence spectrum of DOX-DS complex and free DOX.